Back to Search
Start Over
A Phase 1 Study of RJMty19: Anti-CD19 Humanized CAR-Engineered Allogeneic Double Negative T Cells in Adults with B-Cell Non-Hodgkin's Lymphoma
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p2094-2094, 1p
- Publication Year :
- 2023
-
Abstract
- Introduction:
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64700532
- Full Text :
- https://doi.org/10.1182/blood-2023-189149